M. Bentata

发表

Efficacy and Tolerability of a Nucleoside Reverse Transcriptase Inhibitor-Sparing Combination of Lopinavir/Ritonavir and Efavirenz in HIV-1-Infected Patients

F. Raffi, C. Michelet, C. Brunet-François, 2005, Journal of acquired immune deficiency syndromes.

Recovery of fat following a switch to nucleoside reverse transcriptase inhibitor‐sparing therapy in patients with lipoatrophy: results from the 96‐week randomized ANRS 108 NoNuke Trial

V. Calvez, C. Katlama, W. Rozenbaum, 2008, HIV medicine.

Immunological success is predicted by enfuvirtide but not interleukin-2 therapy in immunodepressed patients

C. Fagard, C. Rouzioux, Y. Lévy, 2009, AIDS.

Prevalence of low bone mineral density in men and women infected with human immunodeficiency virus 1 and a proposal for screening strategy.

D. Costagliola, C. Roux, M. Valantin, 2012, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.

Survival improvement of AIDS-related progressive multifocal leukoencephalopathy in the era of protease inhibitors. Clinical Epidemiology Group. French Hospital Database on HIV.

D. Costagliola, J. Tassie, J. Deloumeaux, 1999, AIDS.

Treatment Intensification with Abacavir in HIV-Infected Patients with at Least 12 Weeks Previous Lamivudine/Zidovudine Treatment

C. Katlama, W. Rozenbaum, P. Massip, 2000, Antiviral therapy.

Favourable Outcome of a Pregnancy with a Maraviroc-Containing Regimen

G. Peytavin, M. Bentata, A. Rodrigues, 2013 .

Effect of alendronate on HIV-associated osteoporosis: a randomized, double-blind, placebo-controlled, 96-week trial (ANRS 120).

D. Costagliola, C. Roux, M. Valantin, 2012, AIDS research and human retroviruses.

Factors associated with clinical and virological failure in patients receiving a triple therapy including a protease inhibitor

D. Costagliola, S. Grabar, P. Fabbro-Péray, 2000, AIDS.

S. Pol, C. Michelet, C. Pradier, 2007, Journal of viral hepatitis.

Early Virologic Failure and Rescue Therapy of Tenofovir, Abacavir, and Lamivudine for Initial Treatment of HIV-1 Infection: TONUS Study

C. Katlama, C. Michelet, G. Peytavin, 2005, HIV clinical trials.

Importance of Baseline Prognostic Factors With Increasing Time Since Initiation of Highly Active Antiretroviral Therapy: Collaborative Analysis of Cohorts of HIV-1-Infected Patients

Anne M Johnson, A. Trkola, J. Sterne, 2007, Journal of acquired immune deficiency syndromes.

Efficacy and safety of ritonavir-boosted dual protease inhibitor therapy in antiretroviral-naive HIV-1-infected patients: the 2IP ANRS 127 study.

F. Brun-Vézinet, C. Katlama, G. Peytavin, 2009, The Journal of antimicrobial chemotherapy.

[Use of enfurvitide in pregnancy in HIV positive women in seven cases].

G. Peytavin, L. Carbillon, C. Alloui, 2009, Gynecologie, obstetrique & fertilite.

Visiting One’s Native Country

B. Spire, P. Carrieri, L. Fugon, 2013, Journal of the International Association of Providers of AIDS Care.

Survival after neuroAIDS

D. Costagliola, C. Dhiver, I. Poizot-Martin, 2011, Neurology.

Causes of the first AIDS‐defining illness and subsequent survival before and after the advent of combined antiretroviral therapy *

D Costagliola, E. Lanoy, D. Costagliola, 2008, HIV Medicine.

Changes in bone mineral density over a 2-year period in HIV-1-infected men under combined antiretroviral therapy with osteopenia

C. Katlama, D. Costagliola, C. Roux, 2013, AIDS.

Candidemia: a nosocomial complication in adults with late-stage AIDS.

O. Lortholary, O. Launay, L. Guillevin, 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Phylogenetic analyses confirm the high prevalence of hepatitis C virus (HCV) type 4 in the Seine-Saint-Denis district (France) and indicate seven different HCV-4 subtypes linked to two different epidemiological patterns.

D. Roulot, O. Lortholary, J. Stirnemann, 2001, The Journal of general virology.

Isoniazid-rifampin fulminant hepatitis. A possible consequence of the enhancement of isoniazid hepatotoxicity by enzyme induction.

D. Pessayre, C. Degott, J. Benhamou, 1977, Gastroenterology.

Risk factors for adherence failure in HIV-infected sub-Saharan migrants living in France and travelling back to their native country

B. Spire, P. Carrieri, L. Fugon, 2014, International journal of STD & AIDS.

Prevalence of low bone mineral density in men and women infected with human immunodeficiency virus 1 and a proposal for screening strategy.

D. Costagliola, C. Roux, M. Valantin, 2012, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.